ArticleStem cell research & therapy2025

Consecutive intrabronchial administration of Wharton's jelly-derived mesenchymal stromal cells in ECMO-supported pediatric patients with end-stage interstitial lung disease: a safety and feasibility study (CIBA method).

Nerea Dominguez-Pinilla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.